טוען...
Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study
PURPOSE: We aimed to evaluate the efficacy and safety of the use of docetaxel plus androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC) in Korean patients. MATERIALS AND METHODS: This study was conducted retrospectively. In total, 61 Korean patients with mHSPC...
שמור ב:
| הוצא לאור ב: | Investig Clin Urol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Urological Association
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495039/ https://ncbi.nlm.nih.gov/pubmed/31098427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2019.60.3.195 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|